To Explore the efficacy of drugs which increase the gastrointestinal motility in Diabetic Gastroparesis.
Not Applicable
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2020/08/027264
- Lead Sponsor
- AIIMS RISHIKESH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All known/diagnosed TYPE 2 diabetic patient with delayed oro cecal transit time (OCTT) diagnosed on lactulose hydrogen breath test
Exclusion Criteria
All Type2 diabetic patient -
-In whom gastro paresis is due to any drug intake like Narcotic pain medicines, Antidepressants Anticholinergics, amylin analogues.
-Who underwent vagotomy / gastric surgery
-Who have thyroid disorder (hypothyroidism) or parkinsonism
-Pregnant females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Explore the efficacy of prokinetic agents in Diabetic GastroparesisTimepoint: TO MEASURE THE CHANGE IN OCTT WITH LACTULOSE HYDROGEN BREATH TEST AFTER 1 MONTH OF DRUG.
- Secondary Outcome Measures
Name Time Method To explore the relative advantage of one over the other prokinetic agents in Diabetic gastroparesis patientsTimepoint: TO MEASURE THE CHANGE IN OCTT WITH LACTULOSE HYDROGEN BREATH TEST AFTER 1 MONTH OF DRUG.